Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GLUT1, encoded by the SLC2A1 gene, is a facilitative glucose transporter protein crucial for transporting glucose across cell membranes. It is essential for tissues with high energy demands, particularly the brain and erythrocytes. GLUT1 mediates glucose uptake in a concentration-dependent manner and is implicated in various diseases, including GLUT1 deficiency syndrome, epilepsy, and cancer. Its role in cancer metabolism makes it a target for therapeutic intervention.
Facilitates passive diffusion of glucose down its concentration gradient.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute Carrier Family 2 Member 1 (GLUT1).